U.S. government-funded HIV medicines delivery should — in theory — continue in Kenya because of a limited waiver to the Trump administration’s global stop work order for the U.S. Agency for International Development’s programming. This waiver allows for “urgent life-saving HIV treatment services” under the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR.
But, in reality, work is stalling because funds aren’t flowing to a key partner organization.
Mission for Essential Drugs & Supplies Centres, or MEDs, the Christian nonprofit that USAID contracts for limited procurement, warehousing, and distribution, doesn’t have the funds to move forward with programming.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
